Acrivon Therapeutics, Inc. Common Stock (ACRV) vs electroCore, Inc. (ECOR)

A side-by-side comparison of Acrivon Therapeutics, Inc. Common Stock and electroCore, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Acrivon Therapeutics, Inc. Common Stock logo
ACRV
Acrivon Therapeutics, Inc. Common Stock
$85M
$1.99HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
electroCore, Inc. logo
ECOR
electroCore, Inc.
$92M
$10.22HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT

Total return — ACRV vs ECOR

growth of $100 · dividends reinvested · last 4y
ACRV -88.1% (-41.3%/yr)ECOR +193.6% (+30.9%/yr)ECOR compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $1002023202420252026$12$294
ACRV ECOR

ACRV vs ECOR: by the numbers

  • •ECOR is the larger company ($92M vs $85M market cap).
  • •Both run net losses; ACRV's is the smaller (0.00% vs -39.96% net margin).

Metrics side by side

Valuation

MetricACRVECOR
P/S ratioN/A2.49
P/B ratio0.98N/A

Profitability

MetricACRVECOR
Gross margin0.00%87.06%
Operating margin0.00%-37.64%
Net margin0.00%-39.96%
ROE-85.65%N/A
ROIC-88.28%-217.73%

Growth (annualized)

MetricACRVECOR
Revenue CAGR (5Y)N/A52.51%
Total return CAGR (5Y)N/A-8.10%

Go deeper

Full ACRV analysisFull ECOR analysisInteractive comparison tool

Dig into the metrics

Acrivon Therapeutics, Inc. Common Stock ROEelectroCore ROEAcrivon Therapeutics, Inc. Common Stock operating marginelectroCore operating marginAcrivon Therapeutics, Inc. Common Stock revenue growthelectroCore revenue growthAcrivon Therapeutics, Inc. Common Stock free cash flowelectroCore free cash flow

Acrivon Therapeutics, Inc. Common Stock & electroCore appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.